Beyond millijoules: a six-dimensional tissue-dose model for fractional ablative carbon dioxide laser therapy
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20263252Keywords:
Ablative fractional laser, Carbon dioxide laser, Dosimetry, Microscopic treatment zone, Tissue response, Wound healingAbstract
Fractional ablative carbon dioxide (CO2) laser treatment is commonly documented with displayed parameters such as pulse energy, power, pulse duration, density level and number of passes. These settings are device-specific inputs, not a portable description of the tissue dose. This perspective proposes a six-dimensional tissue-dose model that represents treatment as a state vector comprising ablation geometry, coagulation geometry, treated fraction, spatial distribution, heat accumulation and healing reserve. The framework was developed through a targeted narrative synthesis of foundational fractional photothermolysis studies, histologic and computational dosimetry work, wound-healing investigations, clinical consensus statements and complication literature. A targeted PubMed, Crossref, journal-archive and web search through 19 August 2026 did not identify a previously published framework integrating the same six dimensions. The model separates the delivered tissue insult from device settings and treats healing reserve as a biological and anatomical constraint on the acceptable exposure. It explains why equal millijoules, equal nominal density or equal total energy can produce different lesion geometry, local overlap, thermal burden and recovery. The framework is intended for treatment planning, cross-platform reporting, education and prospective data collection; it is not a validated dose calculator and does not support universal presets. Validation should combine expert content assessment, platform-specific histology or optical imaging, a common clinical data dictionary and prospective prediction of efficacy, delayed healing, postinflammatory hyperpigmentation and scarring. A shared six-dimensional vocabulary may improve reproducibility while preserving the site-and patient-specific judgment required for safe fractional ablative laser therapy.
References
Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426-38.
Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):87-95.
Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):96-107.
Bedi VP, Chan KF, Sink RK, Hantash BM, Herron GS, Rahman Z, et al. The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing. Lasers Surg Med. 2007;39(2):145-55.
Grunewald S, Bodendorf M, Illes M, Kendler M, Simon JC, Paasch U. In vivo wound healing and dermal matrix remodelling in response to fractional CO2 laser intervention: clinicopathological correlation in non-facial skin. Int J Hyperthermia. 2011;27(8):811-8.
Marqa MF, Mordon S. Laser fractional photothermolysis of the skin: numerical simulation of microthermal zones. J Cosmet Laser Ther. 2014;16(2):57-65.
Taudorf EH, Haak CS, Erlendsson AM, Philipsen PA, Anderson RR, Paasch U, et al. Fractional ablative erbium YAG laser: histological characterization of relationships between laser settings and micropore dimensions. Lasers Surg Med. 2014;46(4):281-9.
Levy T, Lerman I, Waibel J, Gauglitz GG, Clementoni MT, Friedmann DP, et al. Expert consensus on clinical recommendations for fractional ablative CO2 laser in facial skin rejuvenation treatment. Lasers Surg Med. 2025;57(1):15-26.
Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med. 2009;41(3):185-8.
Duplechain JK. Severe neck scarring: a consequence of fractional CO2 laser resurfacing. J Cosmet Laser Ther. 2016;18(6):352-4.
Wu X, Cen Q, Jin J, Gao W, Shang Y, Huang L, et al. An effective and safe laser treatment strategy of fractional carbon dioxide laser for Chinese populations with periorbital wrinkles: a randomized split-face trial. Dermatol Ther (Heidelb). 2025;15(6):1307-17.
Oloruntoba AI, Rodrigues M. Safety and tolerability of fractional CO2 lasers for facial rejuvenation across Fitzpatrick skin phototypes I-IV: retrospective cohort study. J Cosmet Dermatol. 2026;25(5):e70917.
Wongdama S, Yenyuwadee S, Li JB, Saokaew S, Kanchanasurakit S, Manuskiatti W. Interventions to prevent postinflammatory hyperpigmentation after laser and energy-based device treatments: a systematic review and network meta-analysis. Lasers Surg Med. 2026;58(3):157-68.
Debeuf MPH, Rauwenhoff MHP, van Geel M, Steijlen PM, Verstraeten VLRM. Biomolecular changes upon ablative laser therapy of the skin: a scoping review. Int J Dermatol. 2026;65(4):753-62.
Tsai MT, Yang CH, Shen SC, Lee YJ, Chang FY, Feng CS. Monitoring of wound healing process of human skin after fractional laser treatments with optical coherence tomography. Biomed Opt Express. 2013;4(11):2362-75.
Bigge S, Mildszus F, Hasenöhrl C. Fractional carbon dioxide laser resurfacing combined with multilayer hyaluronic acid skinbooster injections for periocular, neck, and décolleté rejuvenation: a prospective multicenter observational interim analysis. J Cutan Aesthet Surg; 2026.
Labadie JG, Ibrahim SA, Worley B, Kang BY, Rakita U, Rigali S, et al. Evidence-based clinical practice guidelines for laser-assisted drug delivery. JAMA Dermatol. 2022;158(10):1193-201.
Ng WHS, Smith SD. Laser-assisted drug delivery: a systematic review of safety and adverse events. Pharmaceutics. 2022;14(12):2738.
Zhu J, Li Y, Wang X, Xiang L, Röcken M, Piguet V, et al. International expert consensus on transdermal drug delivery technologies in dermatology. JAAD Int. 2026;27:169-77.
Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen J, et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017;153(8):802-9.